Evidence map›Paper›PMID 32791705›Full record

Observational studyMedicine2020

Comparison of clinicopathologic profiles and prognosis of gastric cancer in the upper, middle and lower third of the stomach: A retrospective cohort study.

Xiaoming Ma, Chengwu Zhang, Cheng Wang, Wei Miao, Wei Zhou, Juan An, Wenjie Qiao, Mingzheng Li, Minggui Lai, Pengjie Yu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Surgical treatment of gastric adenocarcinoma: what factors influence the prognosis?Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2025
    Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xiaoming MaDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Chengwu ZhangDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Cheng WangDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Wei MiaoDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Wei ZhouDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Juan AnCollege of Basic Medicine, Qinghai University.
Wenjie QiaoDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Mingzheng LiDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Minggui LaiDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Pengjie YuDepartment of Gastrointestinal Tumor Surgery, the Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University.
Qinghai University Affiliated Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is the fourth most common cancer in the world and the second most common cancer in China. The aim of this study was to investigate the clinicopathologic profiles and prognosis of GC in the upper third (UT), middle third (MT) and low third (LT) of the stomach.Five hundred and forty-two patients with GC resected between January 2010 and January 2014 were retrospectively studied and divided in 3 groups according to cancer location: upper third gastric cancer (UTGC) (n = 62); MTGC (n = 131) and LTGC (n = 349). Clinical and pathological parameters including gender, age, tumor size, macroscopic types, histological types, depth of invasion, lymph node metastasis, venous infiltration and lymph embolism were compared among groups. Overall survival (OS) was calculated based on the aforementioned parameters. Univariate and multivariate survival was analyzed and Cox regression was conducted for each location. The prognostic accuracy was determined using receiver operating characteristic curve analysis.Patients with UTGC was similar to those with MTGC and both were distinct from those with LTGC based on the tumor size, macroscopic types, depth of invasion and 5-year OS. Patients with MTGC were similar to those with LTGC and distinct from UTGC patients based on gender. 5-year OS were lower for patients with UTGC than those with LTGC (P = .001) and were comparable between MTGC and LTGC. No significant differences in 5-year OS were observed between UTGC and MTGC. Cox regression revealed that macroscopic types, depth of invasion and lymph node metastasis were the independent prognostic factors for GC patients regardless of locations. Receiver operating characteristic curve analysis revealed that macroscopic types, depth of invasion and lymph node metastasis were the significantly effective prognosis for the 5-year OS in GC patients regardless of locations.Our results showed that UTGC is distinct from LTGC whereas MTGC shares some characteristics from both UTGC and LTGC.

Indexed as

AdultAgedFemaleHumansLymphatic MetastasisMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesROC CurveStomach Neoplasms

Identifiers

PMID32791705
PMCPMC7387008
OpenAlexW3045385557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.